stella
beta
TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response — Stella
Home
/
Crohn Disease (CD)
/
View on ClinicalTrials.gov
Recruiting
Back to Crohn Disease (CD) trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
China
The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong